Q11585 (Q11585): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
18,477,266.6 Czech koruna
| |||||||||||||||
| Property / EU contribution: 18,477,266.6 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
739,090.6640000001 Euro
| |||||||||||||||
| Property / EU contribution: 739,090.6640000001 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 739,090.6640000001 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 739,090.6640000001 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
32,195,969.0 Czech koruna
| |||||||||||||||
| Property / budget: 32,195,969.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
1,287,838.76 Euro
| |||||||||||||||
| Property / budget: 1,287,838.76 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 1,287,838.76 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 1,287,838.76 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 01:18, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
18,477,266.6 Czech koruna
0 references
32,195,969.0 Czech koruna
0 references
57.3899999717356 percent
0 references
31 October 2020
0 references
GeneProof a.s.
0 references
49°9'23.83"N, 16°36'33.98"E
0 references
61900
0 references
61900
0 references
Cílem projektu je výzkum a vývoj plně automatizovaného molekulárně diagnostického procesu a aplikačních diagnostických prostředků pro diagnostiku závažných infekčních a genetických onemocnění založeného na metodě polymerázové řetězové reakce PCR (Polymerase Chain Reaction).Konečným cílem výzkumně-vývojových prací bude: prototyp přístroje MyCrobe Advanced připravený pro sériovou výrobu a užitný vzor: Izolační souprava neenzymatické izolace GeneProof. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_106/0012292
0 references